MetaCap

Nuvectis Pharma Statistics

NASDAQ: NVCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

19.39-0.45 (-2.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Nuvectis Pharma by the numbers

Nuvectis Pharma has a market capitalization of $666.8 million based on 34.39M shares outstanding. With trailing EPS of $-2.00, Nuvectis Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.0% below its 50-day average and 25.4% above its 200-day average.

Average daily trading volume is 206.37K shares, or about $4.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NVCT valuation vs. peer median

NVCT compared with the median of 8 peer companies
MetricNVCTPeer medianDifference
Market cap$666.80M$641.45M+4%
Avg. volume206.37K1.25M-84%

Peer median across 8 companies: APMD, LXRX, SGMT, KURA, JANX, ABUS, OLMA, OBX.

Valuation

Price and trading

Previous close
19.84
Open
19.60
Day range
19.02 – 20.18
52-week range
5.77 – 29.28
52-week change
+218.91%
Beta
—
Volume
301.60K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
666.80M
Forward Pe
-20.20
Eps
-2.00
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
29.28
Week52 Low
5.77
Avg Volume
206.37K
Shares Outstanding
34.39M
Ma50
20.21
Ma200
15.46
Earnings Date
Nov 4, 2026
Pct From52w High
-33.77%
Pct From52w Low
236.05%

Related